We are live on
!
Find out more
MG
Meditor Group Portfolio holdings
AUM
$48.1M
1-Year Est. Return
38.67%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$738M
AUM Growth
–
Cap. Flow
+$747M
Cap. Flow
% of AUM
101.22%
Top 10 Holdings %
Top 10 Hldgs %
70.61%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$88.6M |
| 2 |
Merck
MRK
|
+$87.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$74.1M |
| 4 |
Exelixis
EXEL
|
+$56.9M |
| 5 |
VVUS
Vivus Inc
VVUS
|
+$54.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.01% |
| 2 | Technology | 12.4% |
| 3 | Communication Services | 11.96% |
| 4 | Financials | 5.33% |
| 5 | Consumer Staples | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$324B
| $86.7M | 11.74% |
+1,956,197
| New | +$87.4M |
|
|
ONXX
2
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $83.5M | 11.31% |
+962,103
| New | +$88.6M |
|
|
3
Alphabet (Google) Class C
GOOG
$3.9T
| $76.9M | 10.41% |
+3,505,089
| New | +$74.1M |
|
|
4
Exelixis
EXEL
$13.9B
| $54.5M | 7.38% |
+12,000,000
| New | +$56.9M |
|
|
VVUS
5
DELISTED
Vivus Inc
VVUS
| $52.9M | 7.17% |
+420,730
| New | +$54.3M |
|
6
Alkermes
ALKS
$8.82B
| $48.8M | 6.6% |
+1,700,000
| New | +$49.5M |
|
7
HP
HPQ
$23.5B
| $41.6M | 5.63% |
+3,691,483
| New | +$37.7M |
|
|
NYX
8
DELISTED
NYSE EURONEXT INC
NYX
| $32.1M | 4.35% |
+776,070
| New | +$30.8M |
|
9
BlackBerry
BB
$5.01B
| $23.1M | 3.13% |
+2,210,000
| New | +$32M |
|
|
SFD
10
DELISTED
SMITHFIELD FOODS,INC
SFD
| $21.3M | 2.89% |
+651,000
| New | +$18.4M |
|
|
URS
11
DELISTED
URS CORP
URS
| $17M | 2.3% |
+360,000
| New | +$16.7M |
|
12
Nektar Therapeutics
NKTR
$2.39B
| $16.7M | 2.27% |
+96,667
| New | +$14.8M |
|
13
Apple
AAPL
$4.89T
| $16.3M | 2.2% |
+1,148,000
| New | +$17.7M |
|
|
LIFE
14
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $16.1M | 2.17% |
+217,000
| New | +$15.8M |
|
15
Ionis Pharmaceuticals
IONS
$9.35B
| $14M | 1.89% |
+520,000
| New | +$11.1M |
|
|
BKS
16
DELISTED
Barnes & Noble
BKS
| $14M | 1.89% |
+1,335,250
| New | +$16.8M |
|
|
ITMN
17
DELISTED
INTERMUNE INC
ITMN
| $13.2M | 1.79% |
+1,375,000
| New | +$13.1M |
|
18
Liberty Global Class C
LBTYK
$3.27B
| $11.5M | 1.56% |
+418,428
| New | +$11.7M |
|
|
WCRX
19
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $11.3M | 1.53% |
+566,000
| New | +$9.59M |
|
|
OREX
20
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $11.1M | 1.5% |
+190,000
| New | +$11.7M |
|
|
OPTR
21
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $6.87M | 0.93% |
+475,000
| New | +$6.92M |
|
22
Universal Health Services
UHS
$9.43B
| $6.7M | 0.91% |
+100,000
| New | +$6.61M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $6.66M | 0.9% |
+70,000
| New | +$6.56M |
|
|
BMC
24
DELISTED
BMC SOFTWARE, INC
BMC
| $6.63M | 0.9% |
+147,000
| New | +$6.63M |
|
25
Alnylam Pharmaceuticals
ALNY
$36.3B
| $4.48M | 0.61% |
+144,647
| New | +$3.85M |
|
Similar funds
BHCM
VMV
BHH
LAMC
MAM
BCM
LOF
CLCM
Meditor Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Meditor Group, which disclosed 40 positions worth $738M. Its ten largest holdings account for 71% of the portfolio.
Its largest position is ONYX PHARMACEUTICALS INC: 962,103 shares worth $83.5M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Technology and Communication Services.
- Meditor Group's largest Q2 2013 buy was ONYX PHARMACEUTICALS INC: 962,103 shares worth $83.5M.
- Meditor Group's ten largest holdings make up 71% of its $738M portfolio in Q2 2013.
- Meditor Group disclosed 40 positions in Q2 2013, its first 13F filing on record.
Based on Meditor Group's 13F filing for Q2 2013, filed 29 Jul 2013.